Michael Heinrich, MD

Rare Disease / Clinical Research

Oregon Health and Science University

PI on 1 trial

ℹ

Specialists are identified from ClinicalTrials.gov principal investigators, PubMed publications, and the NPI registry, then ranked through an automated scoring pipeline.

Report missing data

Rare diseases treated or studied

Based on trial PI assignments and publication topics.

Chronic mast cell leukemia
Rare vascular disease
Rare uterine cancer
Rare neurologic disease
Mast cell sarcoma
Rare hemorrhagic disorder
Liposarcoma
Rare urinary tract tumor
Systemic mastocytosis
Melanoma of soft tissue
Thymic epithelial neoplasm
Neuroectodermal-endocrine syndrome
Bronchial neuroendocrine tumor
Mixed germ cell tumor
Rare skin disease
Rare ovarian cancer
Invasive mole
Mastocytosis
Rare respiratory tumor
Rare malignant breast tumor
Acute mast cell leukemia
Rare urogenital tumor
Mixed connective tissue disease
Rare nevus
Rare circulatory system disease
Leiomyosarcoma
Synovial sarcoma
Benign schwannoma
Solitary fibrous tumor
Angiosarcoma

Clinical trials (1)

NCT00154388

Verify independently

ClinicalTrials.gov PI search for Michael Heinrich, MD

Other specialists for Chronic mast cell leukemia

Peers ranked by clinical-trial PI role, publications, and verification quality.

Brenda Sandmaier
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium
WA
David Maloney
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium
Jorge Cortes, MD
UT MD Anderson Cancer Center
Kyoo H. Lee, MD
Asan Medical Center
Maryam Fouladi, MD
COG Phase I Consortium
OH
Marie Bleakley, MD
Fred Hutch/University of Washington Cancer Consortium
WA
Ryotaro Nakamura
City of Hope Medical Center
California
Neal Flomenberg, MD, M.D
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University
PA

See all specialists for Chronic mast cell leukemia →

← Back to specialists directory